Close Window

Digital Look Email A Friend

GSK advances low-carbon inhaler, halts latozinemab study after mixed data

Published by Iain Gilbert on 22nd October 2025

(Sharecast News) - Drugmaker GSK released two sets of trial data on Wednesday, covering its low-carbon asthma inhaler and a potential new treatment for multiple sclerosis.

URL: http://www.digitallook.com/dl/news/story/35439496/...

Email this article to your friends
NOTE: These email addresses will be used to email the information on your behalf and will not be collected by Digital Look for any marketing purposes.